The notes, which are due 2027, are subject to market and other conditions, and the Chicago-based EHR vendor expects to grant initial purchasers of the notes an option to purchase an additional $30 million aggregate principal amount of the notes, according to the report.
Allscripts plans to use a portion of the profits from the offering to pay the cost of capped call transactions, which the company intends to establish with certain initial purchasers and/or their respective affiliates. Allscripts expects to use the remaining profits to repay outstanding borrowings under its senior secured revolving credit facility. Allscripts will not be able to redeem the notes until Jan. 1, 2027.
The interest rate, conversion rate and other terms of the notes will be determined by negotiations between Allscripts and other initial purchasers.
To access Allscripts’ complete announcement, click here.
More articles on EHRs:
Bayhealth deploys Apple’s Health Records app: 4 notes
Cerner CEO unveils next layer of Amazon partnership
Allscripts’ budgeting platform unveils analytics services
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
